These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 25343854

  • 41. Prediction of clinical benefit from androgen deprivation therapy in salivary duct carcinoma patients.
    van Boxtel W, Verhaegh GW, van Engen-van Grunsven IA, van Strijp D, Kroeze LI, Ligtenberg MJ, van Zon HB, Hendriksen Y, Keizer D, van de Stolpe A, Schalken JA, van Herpen CM.
    Int J Cancer; 2020 Jun 01; 146(11):3196-3206. PubMed ID: 31745978
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Three new cases of salivary duct carcinoma in the palate: a radiologic investigation and review of the literature.
    Huh KH, Heo MS, Lee SS, Choi SC.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 Jun 01; 95(6):752-60. PubMed ID: 12789160
    [Abstract] [Full Text] [Related]

  • 44. Genomic landscape of salivary gland tumors.
    Kato S, Elkin SK, Schwaederle M, Tomson BN, Helsten T, Carter JL, Kurzrock R.
    Oncotarget; 2015 Sep 22; 6(28):25631-45. PubMed ID: 26247885
    [Abstract] [Full Text] [Related]

  • 45. Targeted deep sequencing of mucinous ovarian tumors reveals multiple overlapping RAS-pathway activating mutations in borderline and cancerous neoplasms.
    Mackenzie R, Kommoss S, Winterhoff BJ, Kipp BR, Garcia JJ, Voss J, Halling K, Karnezis A, Senz J, Yang W, Prigge ES, Reuschenbach M, Doeberitz MV, Gilks BC, Huntsman DG, Bakkum-Gamez J, McAlpine JN, Anglesio MS.
    BMC Cancer; 2015 May 19; 15():415. PubMed ID: 25986173
    [Abstract] [Full Text] [Related]

  • 46. Next-Generation Sequencing in Salivary Gland Basal Cell Adenocarcinoma and Basal Cell Adenoma.
    Wilson TC, Ma D, Tilak A, Tesdahl B, Robinson RA.
    Head Neck Pathol; 2016 Dec 19; 10(4):494-500. PubMed ID: 27224988
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Detailed genome-wide SNP analysis of major salivary carcinomas localizes subtype-specific chromosome sites and oncogenes of potential clinical significance.
    Zhang L, Mitani Y, Caulin C, Rao PH, Kies MS, Saintigny P, Zhang N, Weber RS, Lippman SM, El-Naggar AK.
    Am J Pathol; 2013 Jun 19; 182(6):2048-57. PubMed ID: 23583282
    [Abstract] [Full Text] [Related]

  • 51. Next generation sequencing in lung cancer: An initial experience from India.
    Gupta P, Saha K, Vinarkar S, Banerjee S, Choudhury SS, Parihar M, Midha D, Mukherjee G, Lingegowda D, Chatterjee S, ArunsinghS M, Shrimali R, Ganguly S, Dabkara D, Biswas B, Mishra DK, Arora N.
    Curr Probl Cancer; 2020 Jun 19; 44(3):100562. PubMed ID: 32178863
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Targeted next-generation sequencing detects a high frequency of potentially actionable mutations in metastatic breast cancers.
    Muller KE, Marotti JD, de Abreu FB, Peterson JD, Miller TW, Chamberlin MD, Tsongalis GJ, Tafe LJ.
    Exp Mol Pathol; 2016 Jun 19; 100(3):421-5. PubMed ID: 27095739
    [Abstract] [Full Text] [Related]

  • 56. First-Line Treatment of Widely Metastatic BRAF-Mutated Salivary Duct Carcinoma With Combined BRAF and MEK Inhibition.
    Lin VTG, Nabell LM, Spencer SA, Carroll WR, Harada S, Yang ES.
    J Natl Compr Canc Netw; 2018 Oct 19; 16(10):1166-1170. PubMed ID: 30323086
    [Abstract] [Full Text] [Related]

  • 57. Salivary duct carcinoma: A case report of oncocytic variant with possible treatment implications and review of literature.
    Sekhri R, Ortanca I, Boals C, Agarwal S.
    Pathol Res Pract; 2019 Oct 19; 215(10):152549. PubMed ID: 31495607
    [Abstract] [Full Text] [Related]

  • 58. Salivary duct carcinoma with rhabdoid features: a salivary counterpart of pleomorphic lobular carcinoma of the breast.
    Kusafuka K, Kawasaki T, Maeda M, Yamanegi K, Baba S, Ito Y, Inagaki H, Nakajima T.
    Histopathology; 2017 Jan 19; 70(2):164-173. PubMed ID: 27079821
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Nonamplification ERBB2 genomic alterations in 5605 cases of recurrent and metastatic breast cancer: An emerging opportunity for anti-HER2 targeted therapies.
    Ross JS, Gay LM, Wang K, Ali SM, Chumsri S, Elvin JA, Bose R, Vergilio JA, Suh J, Yelensky R, Lipson D, Chmielecki J, Waintraub S, Leyland-Jones B, Miller VA, Stephens PJ.
    Cancer; 2016 Sep 01; 122(17):2654-62. PubMed ID: 27284958
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.